Blood Neoplasia
Издатель: Elsevier · ISSN 2950-3280 · 100 статей
- Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey
- Combination therapy with nelarabine, pegaspargase, and venetoclax for adult patients with R/R T-cell ALL/LBL
- GATA-3 identifies a distinct subset of T-PLL associated with skin involvement and CCR4 expression
- MCL1 inhibition exerts potent antileukemic activity by restoring apoptosis in T-lineage acute lymphoblastic leukemia
- Venetoclax plus hypomethylating agent improves response rates but not survival in TP53-mutated myelodysplastic syndromes
- Adkins J, Zhao C. Lineage switch in leukemia and lymphoma: case reports and molecular and cellular mechanisms. Blood Neoplasia. 2026;3(4):100265.
- PLK4 inhibition by CFI-400945 triggers polyploidy and synergistic apoptosis with venetoclax in TP53-mutant AML
- Circulating Multiple Myeloma Cell Kinetics and Genomic Profiling Predict Resistance to Targeted Immunotherapies
- Dual EZH2 & Histone Deacetylase Inhibition Suppresses Cell Viability in Down Syndrome Myeloid Leukemia by Depleting EZH2
- Actimab-A, a CD33-targeted Actinium-225 radioconjugate, drives potent mutation-agnostic efficacy in AML models